Ferguson Veterinary Clinic and Orthopaedic Referrals Limited 14163039 false 2022-06-09 2023-06-30 2023-06-30 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true true 14163039 2022-06-09 2023-06-30 14163039 2023-06-30 14163039 core:RetainedEarningsAccumulatedLosses 2023-06-30 14163039 core:ShareCapital 2023-06-30 14163039 core:CurrentFinancialInstruments core:WithinOneYear 2023-06-30 14163039 bus:SmallEntities 2022-06-09 2023-06-30 14163039 bus:AuditExemptWithAccountantsReport 2022-06-09 2023-06-30 14163039 bus:FullAccounts 2022-06-09 2023-06-30 14163039 bus:SmallCompaniesRegimeForAccounts 2022-06-09 2023-06-30 14163039 bus:RegisteredOffice 2022-06-09 2023-06-30 14163039 bus:Director1 2022-06-09 2023-06-30 14163039 bus:PrivateLimitedCompanyLtd 2022-06-09 2023-06-30 14163039 core:PlantMachinery 2022-06-09 2023-06-30 14163039 countries:EnglandWales 2022-06-09 2023-06-30 iso4217:GBP xbrli:pure

Registration number: 14163039

Ferguson Veterinary Clinic and Orthopaedic Referrals Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Period from 9 June 2022 to 30 June 2023

 

Ferguson Veterinary Clinic and Orthopaedic Referrals Limited

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

Ferguson Veterinary Clinic and Orthopaedic Referrals Limited

(Registration number: 14163039)
Abridged Balance Sheet as at 30 June 2023

Note

2023
£

Fixed assets

 

Tangible assets

4

67,500

Current assets

 

Debtors

9,766

Cash at bank and in hand

 

1,681

 

11,447

Creditors: Amounts falling due within one year

(94,690)

Net current liabilities

 

(83,243)

Net liabilities

 

(15,743)

Capital and reserves

 

Called up share capital

100

Profit and loss account

(15,843)

Total equity

 

(15,743)

For the financial period ending 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the director on 5 March 2024
 

Mr J Ferguson

Director

 

Ferguson Veterinary Clinic and Orthopaedic Referrals Limited

Notes to the Unaudited Abridged Financial Statements for the Period from 9 June 2022 to 30 June 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU
Somerset

These financial statements were authorised for issue by the director on 5 March 2024.

2

Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis. Of the company's current liabilities at 30 June 2023, an amount is owed to the director, who has agreed to continue to support the company, and not to demand repayment of this amount to the extent that any such repayment would jeopardise the future of the company.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

25% reducing balance

 

Ferguson Veterinary Clinic and Orthopaedic Referrals Limited

Notes to the Unaudited Abridged Financial Statements for the Period from 9 June 2022 to 30 June 2023

3

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

4

Tangible assets

Total
£

Cost or valuation

Additions

67,500

At 30 June 2023

67,500

Depreciation

Carrying amount

At 30 June 2023

67,500